Relationship between c-erbB-2 immunoreactivity and thymidine labelling index in breast carcinomain situ
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://link.springer.com/content/pdf/10.1007/BF01975438.pdf
Reference23 articles.
1. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL: Amplification of the her-2/neu oncogene correlates with relapse and survival in human cancer. Science 235: 177–182, 1987
2. Barnes DM, Lammie GA, Millis RR, Gullick WL, Allen DS, Altman DG: An immunohistochemical evaluation of c-erbB-2 expression in human breast carcinoma. Br J Cancer 58: 448–452, 1988
3. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Sutart SG, Udove J, Ullrich A, Press MF: Studies of the her-2/neu proto-oncogene in human breast and ovarian cancer. Science 244: 707–712, 1989
4. van de Vijver, Peterse JL, Mooi WJ, Wisman P, Lomans J, Dalesio O, Nusse R: Neu-protein overexpression in breast cancer. Association with comedo type ductal carcinomain situ and limited prognostic value in stage II breast cancer. N Engl J Med 319: 1239–1245, 1988
5. Bartkova J, Barnes DM, Millis RR, Gullick WJ: Immunohistochemical demonstration of c-erbB-2 protein in mammary ductal carcinomain situ. Human Pathol 21: 1164–1167, 1990
Cited by 55 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. N-Acetylglucosaminyltransferase III (GnT-III) but not N-Acetylgalactosaminyltransferase-6 and 8 are Differentially Expressed in Invasive and In Situ Ductal Carcinoma of the Breast;Pathology & Oncology Research;2019-01-28
2. Ductal Carcinoma in Situ of the Breast;The Breast;2018
3. Surgical Treatment of Ductal Carcinoma In Situ;Atypical Breast Proliferative Lesions and Benign Breast Disease;2018
4. Current Approaches to Diagnosis and Treatment of Ductal Carcinoma In Situ and Future Directions;Progress in Molecular Biology and Translational Science;2017
5. Ductal Carcinoma In Situ of the Breast;Breast Cancer;2013-08-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3